News

Bristol-Myers Squibb Company and Pfizer Inc. announced that eight abstracts have been accepted for presentation at the American College of Cardiology (ACC) 66th Annual Scientific Session, taking place March 17-19 in Washington, D.C. In...

OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, announced the first closing of a Series B financing round of €8.3 million and...

Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced that Takatsuki General Hospital, a leading acute care institution near Osaka, has completed 250 ablation procedures...

Abiomed, Inc., a leading provider of breakthrough heart support technologies, announced that it has supported more than 50,000 patients in the U.S. with its Impella® line of heart pumps. Impella heart pumps enable minimally invasive treatment...

Suite of Smart Heart Failure Devices Offers More-Effective Pacing, Expanded MRI Access Medtronic plc announced that it has received CE (Conformité Européenne) Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers...

Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, announced the issuance on January 24, 2017 by the U.S. Patent and Trademark Office (USPTO) of a new patent covering the...

SentreHEART, Inc., developer and manufacturer of the percutaneous LARIAT® Suture Delivery Device (LARIAT) and ECLIPSE™ Surgical Left Atrial Appendage Closure (LAAC) Device, announced that the German Institute for the Hospital Remuneration...

AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG/EKG) technology, was named as one of the Top 10 Most Innovative Companies in Health for 2017 by Fast Company as part of the publication's annual ranking of the world's Most...

Medtronic plc announced that the U.S. Centers for Medicare and Medicaid Services (CMS) will cover leadless cardiac pacemakers, as outlined in the agency's final National Coverage Determination (NCD). This decision will provide Medicare...